Abstract
Nucleophosmin/B23 was first identified as a nucleolar protein expressed at higher levels in cancer cells compared to normal cells. Nucleophosmin/B23 has long been thus thought to have a role in tumor formation. With our efforts and others in the last 15 years, nucleophosmin/B23 has proven to have an oncogenic role. In this review, we provide evidence suggesting that nucleophosmin/B23 may be a crucial gene in regulation of cancer growth and discuss how nucleophosmin/B23 can contribute to tumorigenesis.
| Original language | English |
|---|---|
| Pages (from-to) | 285-293 |
| Number of pages | 9 |
| Journal | Chang Gung Medical Journal |
| Volume | 30 |
| Issue number | 4 |
| Publication status | Published - 1 Jul 2007 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Nucleolus
- Nucleophosmin/B23
- Tumorigenesis
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Oncogenic role of nucleophosmin/B23'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver